跳至主要内容
临床试验/ACTRN12620000860965
ACTRN12620000860965尚未招募未知

A randomised controlled trial on the effect of a smart device enabled monitoring system on management of heart failure among patients with pre-existing left ventricular dysfunction during COVID-19 isolation

Wesley Medical Research0 个研究点目标入组 400 人开始时间: 2020年8月28日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Aged 18 years and over at the time of consent
  • 2.Left Ventricular (LV) Dysfunction or heart failure, defined as:
  • a.Reduced LV function on echocardiography – either current or previous which has normalised on therapy
  • b.Prior symptomatic heart failure events including preserved LV function
  • 3.Technical skills to use smart device, as assessed by a standard screening tool
  • 4.Appropriate smart device
  • 5.Informed consent to participate

排除标准

  • 1.Other terminal disease
  • 2.Impaired cognitive function that precludes regular use of the app system
  • 3.Planned transfer of care to a different geographical location

研究者

相似试验